Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
A concise comparison answering Which Performs Better Index Fund Or Target Date Fund, focusing on performance, risk, and long-term suitability.
25,681 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Goldman Sachs has quietly built a $154 million stake in spot XRP ETFs, making it the largest disclosed holder as XRP ...
Elon Musk announced a Texas-based Terafab chip initiative, a joint venture between TESLA and SPACE X, to build advanc...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
A wave of AI-powered servicing messages is misinforming borrowers, exposing a governance gap in mortgage operations. ...
Three under-$10 energy names are drawing attention as one yields 8.8%, another is up 83% in a year, and market chatte...
Stocks edge higher as Nvidia earnings loom, lifting the S&P 500 and Nasdaq. This stock market live 2026 update tracks...
Bitcoin’s trade flips bond as the bond market takes control of financial conditions, signaling a pivot from easy-mone...
Microsoft is pursuing a unifying Copilot hub to combine its AI tools into one experience, with a late-summer 2026 rol...
Markets brace for Kevin Warsh's first Fed meeting amid stubborn inflation and political scrutiny. Observers ask wheth...
An AI-driven forecast in June 2026 warns of potential further weakness for XRP, signaling price targets that could un...
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...